Allergy Therapeutics To Enter U.S. Allergy Market With 2019 Launch
This article was originally published in The Pink Sheet Daily
Executive Summary
Launch of the first FDA-approved subcutaneous allergy vaccine may be four years away, but the European specialty company is starting to plan for commercialization and market growth.